MedPage Today on MSN

For your patients: Understanding your treatment options

After stomach cancer is diagnosed, a team of cancer specialists will work together with you to develop a personalized ...

Angitia Biopharmaceuticals Announces Dosing of First Participant in Phase 2 IDUN Trial of AGA2115 for the Treatment of Osteogenesis Imperfecta

Phase 2 trial of adults with Osteogenesis Imperfecta (OI) is enrolling patients in the US and EU WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a ...